PharmaCyte Biotech, Inc.

PMCB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 2 employees
229
SEC Filings
$0.3401
Close 2026-11-03
2
Employees

Business Summary

PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer using its proprietary Cell-in-a-Box live cell encapsulation technology. Its lead product candidate, CypCaps, encapsulates genetically engineered human cells that convert a cancer prodrug into its active cancer-killing form, targeting locally advanced, inoperable, non-metastatic pancreatic cancer (LAPC). The company submitted an IND to the FDA in 2020, which was placed on clinical hold pending resolution of nonclinical and manufacturing requirements.

Latest Stock Quote

PMCB 2026-11-03 $0.3401 O:$0.3164 H:$0.3402 L:$0.3164 Vol:0.1M VWAP:$0.3296
origin leaf: null

Next Earnings

expected 2027-01-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-07-292026-04-300001683168-26-005836EDGAR110K words
2025-08-112025-04-300001683168-25-005821EDGAR103K words
2024-08-132024-04-300001683168-24-005575EDGAR98K words
2023-07-312023-04-300001683168-23-005175EDGAR87K words
2022-07-282022-04-300001683168-22-005189EDGAR91K words
2021-08-102021-04-300001683168-21-003377EDGAR100K words
2020-08-132020-04-300001683168-20-002680EDGAR93K words
2019-08-132019-04-300001683168-19-002559EDGAR93K words
2018-07-202018-04-300001683168-18-001994EDGAR94K words
2017-07-272017-04-300001683168-17-001881EDGAR87K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-09-142026-07-310001683168-26-007106EDGAR22K words
2026-03-172026-01-310001683168-26-001917EDGAR30K words
2025-12-182025-10-310001683168-25-009259EDGAR29K words
2025-09-152025-07-310001683168-25-006991EDGAR21K words
2025-03-172025-01-310001683168-25-001669EDGAR26K words
2024-12-132024-10-310001683168-24-008709EDGAR25K words
2024-09-172024-07-310001683168-24-006441EDGAR23K words
2024-03-182024-01-310001683168-24-001525EDGAR29K words
2023-12-152023-10-310001683168-23-008889EDGAR27K words
2023-09-182023-07-310001683168-23-006505EDGAR25K words
2023-03-162023-01-310001683168-23-001559EDGAR27K words
2022-12-142022-10-310001683168-22-008428EDGAR27K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-130001683168-26-008705EDGAR1K words
2026-10-160001683168-26-007934EDGAR1K words
2026-04-020001683168-26-002613EDGAR12K words
2025-12-050001683168-25-008947EDGAR1K words
2025-10-310001683168-25-007871EDGAR12K words
2025-09-050001683168-25-006727EDGAR0K words
2025-08-180001683168-25-006274EDGAR1K words
2025-04-240001683168-25-002790EDGAR1K words
2025-02-260001683168-25-001236EDGAR1K words
2024-05-230001683168-24-003796EDGAR1K words

229 total filings indexed. 197 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

oncology pancreatic-cancer-treatment cellular-therapy surgical-resection-enablement-for-lapc

Company Identity

CIK0001157075
TickerPMCB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV
Websitehttps://pharmacyte.com
Listed2003-09-11

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: cb93f6bb77d6ae64d164d3d00ccf4f57b1eb6b7c943b1c827f4703e2703e79f6
parent: 64a6adf14040d9580a5a0c316d3575fa91ccf4cc6a6f4a4d7d930395cdf26297
content hash: ef62672013437f261f919db16495013d24071faa08c952a914c24d3e23ba46de
signed: 2026-11-16T19:04:12.697Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PMCB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PMCB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PMCB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.